The beneficial effect of probiotics as an adjuvant treatment in childhood drug resistant epilepsy: A prospective pilot study
International Journal of Immunopathology and Pharmacology · 2024-01 · 38
DOI: 10.1177/03946320241291276 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, online erschienen am 07.10.2024. Verfasst von Ossama Salah El-Sharkawy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ain-Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Probiotics, Quality of Life, Drug Resistant Epilepsy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
One of the most common long-term neurological disorders affecting children is epilepsy. Even with effective antiseizure medications, one-third of epileptic patients develop drug-resistant epilepsy (DRE). Numerous treatments have been offered to these DRE patients, though with varying degrees of effectiveness.
Objectives
This study aimed to evaluate the effectiveness of probiotics in improving the quality of life (QoL) and lowering the severity and frequency of epileptic episodes in DRE patients. As well as to assess the anti-inflammatory effects of probiotics.
Methods
DRE patients were daily supplemented with one probiotic for 4 months. During these 4 months, patients continued their routine anti-epileptics with no change in the doses. Before and following the 4-month trial, patients had their QoL evaluated using the validated Arabic version of QoL in epilepsy-31 inventory (QoLIE-31) questionnaire, an electroencephalogram (EEG) examination, and serum soluble CD14 (sCD14) evaluation by ELISA.
Results
Of the 21 DRE patients who completed the study, 42.9% achieved the therapeutic goal, which was a ≥50% reduction in seizures. After probiotic, there was a significant increase in time elapsed since the last seizure ( p = 0.001) and a decrease in seizure duration ( p = 0.038), frequency ( p = 0.002), and severity by Chalfont Seizure Severity Score ( p < 0.001), as compared to pre-probiotic data. Moreover, there was a significant decrease in serum levels of sCD14 ( p < 0.001) and a significant improvement in QoL ( p < 0.05).
Conclusion
Probiotics may be used as a DRE adjuvant treatment. They can lessen the number and severity of seizures, alleviate the associated inflammation, and enhance the QoL for DRE patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Ain-Shams University, Cairo, Egypt.
- Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
ORCID-Profile: Sara I Taha
Zitieren
APA
El-Sharkawy, O. S., El-Rashidy, O. F., Elagouza, I. A. A., Nassar, B. A., & Taha, S. I. (2024). The beneficial effect of probiotics as an adjuvant treatment in childhood drug resistant epilepsy: A prospective pilot study. International Journal of Immunopathology and Pharmacology, 38. https://doi.org/10.1177/03946320241291276
Vancouver
El-Sharkawy OS, El-Rashidy OF, Elagouza IAA, Nassar BA, Taha SI. The beneficial effect of probiotics as an adjuvant treatment in childhood drug resistant epilepsy: A prospective pilot study. International Journal of Immunopathology and Pharmacology. 2024;38. doi:10.1177/03946320241291276
BibTeX
@article{ElSharkawy2024,
author = {El-Sharkawy, Ossama Salah and El-Rashidy, Omnia Fathy and Elagouza, Iman Ali Abdelhamid and Nassar, Bassant A and Taha, Sara I},
title = {The beneficial effect of probiotics as an adjuvant treatment in childhood drug resistant epilepsy: A prospective pilot study},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2024},
volume = {38},
doi = {10.1177/03946320241291276}
}
EUVIMED